Declared Dividend • Jun 08
Dividend of CN¥0.01 announced Shareholders will receive a dividend of CN¥0.01. Ex-date: 9th June 2026 Payment date: 9th June 2026 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (87% earnings payout ratio) and cash flows (14% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 134% over the next 3 years, which should provide support to the dividend and adequate earnings cover. New Risk • May 12
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 643% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.9% net profit margin). Major Estimate Revision • Apr 29
Consensus revenue estimates fall by 37% The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from CN¥2.28b to CN¥1.43b. EPS estimate fell from CN¥0.18 to CN¥0.05 per share. Net income forecast to grow 76% next year vs 56% growth forecast for Chemicals industry in China. Consensus price target of CN¥7.23 unchanged from last update. Share price fell 3.9% to CN¥15.20 over the past week. Reported Earnings • Apr 23
First quarter 2026 earnings released: EPS: CN¥0.012 (vs CN¥0.033 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.012 (down from CN¥0.033 in 1Q 2025). Revenue: CN¥300.8m (down 7.3% from 1Q 2025). Net income: CN¥14.3m (down 57% from 1Q 2025). Profit margin: 4.8% (down from 10% in 1Q 2025). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 51% per year, which means it is well ahead of earnings. Announcement • Apr 23
Chongqing Zaisheng Technology Co., Ltd., Annual General Meeting, May 14, 2026 Chongqing Zaisheng Technology Co., Ltd., Annual General Meeting, May 14, 2026, at 14:00 China Standard Time. Location: 5F, No. 1, Chanyi Road, Huixing Subdistrict, Yubei District, Chongqing China Board Change • Apr 05
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Xuejun Sheng was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Mar 30
Chongqing Zaisheng Technology Co., Ltd. to Report Q1, 2026 Results on Apr 23, 2026 Chongqing Zaisheng Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026 Announcement • Jan 07
Zhongrong Huaxin International Biotechnology (Beijing) Co., Ltd. cancelled the acquisition of 6.04% stake in Chongqing Zaisheng Technology Co., Ltd. (SHSE:603601) from Guo Mao. Zhongrong Huaxin International Biotechnology (Beijing) Co., Ltd. signed Share Transfer Agreement to acquire 6.04% stake in Chongqing Zaisheng Technology Co., Ltd. (SHSE:603601) from Guo Mao for approximately CNY 340 million on December 8, 2025. As part of acquisition, 62,187,200 shares will be acquired for CNY 5.53 per share. After completion of transaction, Guo Mao stake will be decrease from 33.13% stake to 27.09% stake.
Zhongrong Huaxin International Biotechnology (Beijing) Co., Ltd. cancelled the acquisition of 6.04% stake in Chongqing Zaisheng Technology Co., Ltd. (SHSE:603601) from Guo Mao on January 5, 2026. Announcement • Dec 26
Chongqing Zaisheng Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026 Chongqing Zaisheng Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026 Valuation Update With 7 Day Price Move • Dec 01
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥5.23, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 2.3% over the past three years. Announcement • Sep 30
Chongqing Zaisheng Technology Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025 Chongqing Zaisheng Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025 Valuation Update With 7 Day Price Move • Sep 04
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥5.22, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 11% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.14 per share. Buy Or Sell Opportunity • Sep 02
Now 23% undervalued Over the last 90 days, the stock has risen 49% to CN¥5.53. The fair value is estimated to be CN¥7.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.1% over the last 3 years. Earnings per share has declined by 50%. Revenue is forecast to grow by 66% in 2 years. Earnings are forecast to grow by 150% in the next 2 years. Reported Earnings • Aug 22
Second quarter 2025 earnings released: EPS: CN¥0.026 (vs CN¥0.043 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.026 (down from CN¥0.043 in 2Q 2024). Revenue: CN¥333.9m (down 19% from 2Q 2024). Net income: CN¥26.7m (down 39% from 2Q 2024). Profit margin: 8.0% (down from 11% in 2Q 2024). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Aug 18
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥5.76, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 24x in the Chemicals industry in China. Total loss to shareholders of 9.9% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.17 per share. Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥4.63, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 22x in the Chemicals industry in China. Total loss to shareholders of 23% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.04 per share. New Risk • Jul 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Jul 01
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥4.47, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 22x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.94 per share. Announcement • Jun 30
Chongqing Zaisheng Technology Co., Ltd. to Report First Half, 2025 Results on Aug 21, 2025 Chongqing Zaisheng Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 21, 2025 Declared Dividend • Jun 06
Dividend of CN¥0.01 announced Shareholders will receive a dividend of CN¥0.01. Ex-date: 11th June 2025 Payment date: 11th June 2025 Dividend yield will be 1.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (78% earnings payout ratio) and cash flows (47% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover. New Risk • May 14
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Major Estimate Revision • Apr 30
Consensus revenue estimates decrease by 17% The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from CN¥1.98b to CN¥1.64b. EPS estimate unchanged from CN¥0.12 per share at last update. Chemicals industry in China expected to see average net income growth of 50% next year. Consensus price target of CN¥4.13 unchanged from last update. Share price was steady at CN¥3.49 over the past week. Reported Earnings • Apr 24
First quarter 2025 earnings released: EPS: CN¥0.033 (vs CN¥0.032 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.033 (up from CN¥0.032 in 1Q 2024). Revenue: CN¥324.5m (down 4.6% from 1Q 2024). Net income: CN¥33.6m (up 3.7% from 1Q 2024). Profit margin: 10% (in line with 1Q 2024). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Announcement • Apr 24
Chongqing Zaisheng Technology Co., Ltd., Annual General Meeting, May 15, 2025 Chongqing Zaisheng Technology Co., Ltd., Annual General Meeting, May 15, 2025, at 14:00 China Standard Time. Location: 5F, No. 1, Chanyi Road, Huixing Subdistrict, Yubei District, Chongqing China Announcement • Mar 28
Chongqing Zaisheng Technology Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025 Chongqing Zaisheng Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025 Announcement • Dec 27
Chongqing Zaisheng Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025 Chongqing Zaisheng Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025 Reported Earnings • Oct 26
Third quarter 2024 earnings released: EPS: CN¥0.014 (vs CN¥0.035 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.014 (down from CN¥0.035 in 3Q 2023). Revenue: CN¥345.3m (down 22% from 3Q 2023). Net income: CN¥14.7m (down 59% from 3Q 2023). Profit margin: 4.3% (down from 8.1% in 3Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 37 percentage points per year, which is a significant difference in performance. Announcement • Sep 30
Chongqing Zaisheng Technology Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024 Chongqing Zaisheng Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024 Reported Earnings • Aug 14
Second quarter 2024 earnings released: EPS: CN¥0.043 (vs CN¥0.047 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.043 (down from CN¥0.047 in 2Q 2023). Revenue: CN¥410.5m (down 7.6% from 2Q 2023). Net income: CN¥43.8m (down 8.8% from 2Q 2023). Profit margin: 11% (in line with 2Q 2023). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 34% per year, which means it has not declined as severely as earnings. Announcement • Jun 28
Chongqing Zaisheng Technology Co., Ltd. to Report First Half, 2024 Results on Aug 14, 2024 Chongqing Zaisheng Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 14, 2024 Declared Dividend • Jun 14
Dividend of CN¥0.03 announced Shareholders will receive a dividend of CN¥0.03. Ex-date: 18th June 2024 Payment date: 18th June 2024 Dividend yield will be 1.0%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (82% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.1% per year over the past 9 years. However, payments have been volatile during that time. EPS is expected to grow by 197% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Major Estimate Revision • May 01
Consensus revenue estimates fall by 29% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥2.35b to CN¥1.67b. EPS estimate fell from CN¥0.24 to CN¥0.23 per share. Net income forecast to grow 532% next year vs 58% growth forecast for Chemicals industry in China. Consensus price target of CN¥3.47 unchanged from last update. Share price rose 6.3% to CN¥3.21 over the past week. Reported Earnings • Apr 26
First quarter 2024 earnings released: EPS: CN¥0.032 (vs CN¥0.033 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.032 (down from CN¥0.033 in 1Q 2023). Revenue: CN¥340.1m (down 9.9% from 1Q 2023). Net income: CN¥32.4m (down 2.7% from 1Q 2023). Profit margin: 9.5% (in line with 1Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings. Announcement • Apr 26
Chongqing Zaisheng Technology Co., Ltd., Annual General Meeting, May 17, 2024 Chongqing Zaisheng Technology Co., Ltd., Annual General Meeting, May 17, 2024, at 14:00 China Standard Time. Location: 5F, No. 1, Chanyi Road, Huixing Subdistrict, Yubei District, Chongqing China Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥2.80, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 64% over the past three years. Announcement • Mar 29
Chongqing Zaisheng Technology Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024 Chongqing Zaisheng Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 25, 2024 Valuation Update With 7 Day Price Move • Mar 20
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥3.82, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥1.92 per share. Price Target Changed • Mar 18
Price target increased by 7.0% to CN¥7.21 Up from CN¥6.73, the current price target is an average from 3 analysts. New target price is 129% above last closing price of CN¥3.15. Stock is down 40% over the past year. The company is forecast to post earnings per share of CN¥0.22 for next year compared to CN¥0.15 last year. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥3.19, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥1.80 per share. Announcement • Dec 29
Chongqing Zaisheng Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024 Chongqing Zaisheng Technology Co., Ltd. announced that they will report fiscal year 2023 results on Apr 25, 2024 Announcement • Sep 30
Chongqing Zaisheng Technology Co., Ltd. to Report Q3, 2023 Results on Oct 27, 2023 Chongqing Zaisheng Technology Co., Ltd. announced that they will report Q3, 2023 results on Oct 27, 2023 New Risk • Aug 06
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Reported Earnings • Aug 03
Second quarter 2023 earnings released: EPS: CN¥0.047 (vs CN¥0.05 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.047 (down from CN¥0.05 in 2Q 2022). Revenue: CN¥444.5m (up 5.3% from 2Q 2022). Net income: CN¥48.0m (down 5.3% from 2Q 2022). Profit margin: 11% (down from 12% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Announcement • Jul 27
Mann+hummel Life Sciences & Environment Holding Singapore Pte. Ltd. agreed 70% stakes in Suzhou U-air Environmental Technology Co.,Ltd. from Chongqing Zaisheng Technology Co., Ltd. (SHSE:603601) for CNY 320 million. Mann+hummel Life Sciences & Environment Holding Singapore Pte. Ltd. agreed 70% stakes in Suzhou U-air Environmental Technology Co.,Ltd. from Chongqing Zaisheng Technology Co., Ltd. (SHSE:603601) for CNY 320 million on July 25, 2023. Suzhou U-air Environmental Technology Co.,Ltd. reported financials for March 31, 2023, total assets of 512.58 million and net assets of CNY 205.58 million. Chongqing Zaisheng Technology Co., Ltd. (SHSE:603601) board of directors and shareholders approved the transaction. Mann+hummel Life Sciences & Environment Holding Singapore Pte. Ltd. completed the acquisition of 70% stakes in Suzhou U-air Environmental Technology Co.,Ltd. from Chongqing Zaisheng Technology Co., Ltd. (SHSE:603601) on July 25, 2023. Announcement • Jun 28
Chongqing Zaisheng Technology Co., Ltd. to Report First Half, 2023 Results on Aug 03, 2023 Chongqing Zaisheng Technology Co., Ltd. announced that they will report first half, 2023 results on Aug 03, 2023 Price Target Changed • May 02
Price target decreased by 7.7% to CN¥7.71 Down from CN¥8.36, the current price target is an average from 3 analysts. New target price is 72% above last closing price of CN¥4.47. Stock is down 20% over the past year. The company is forecast to post earnings per share of CN¥0.20 for next year compared to CN¥0.15 last year. Reported Earnings • Apr 26
First quarter 2023 earnings released: EPS: CN¥0.033 (vs CN¥0.058 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.033 (down from CN¥0.058 in 1Q 2022). Revenue: CN¥377.4m (up 2.5% from 1Q 2022). Net income: CN¥33.3m (down 44% from 1Q 2022). Profit margin: 8.8% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 22% per year whereas the company’s share price has fallen by 20% per year. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 4 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Major Estimate Revision • Nov 04
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate fell from CN¥0.25 to CN¥0.19. Revenue forecast unchanged from CN¥1.66b at last update. Net income forecast to grow 38% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥8.19. Share price rose 4.0% to CN¥5.43 over the past week. Reported Earnings • Oct 29
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2022 results: EPS: CN¥0.034 (down from CN¥0.046 in 3Q 2021). Revenue: CN¥407.5m (up 11% from 3Q 2021). Net income: CN¥34.2m (down 27% from 3Q 2021). Profit margin: 8.4% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) missed analyst estimates by 40%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 4% per year. Price Target Changed • Oct 23
Price target decreased to CN¥8.36 Down from CN¥9.25, the current price target is an average from 3 analysts. New target price is 52% above last closing price of CN¥5.50. Stock is down 33% over the past year. The company is forecast to post earnings per share of CN¥0.25 for next year compared to CN¥0.25 last year. Price Target Changed • Sep 07
Price target decreased to CN¥8.27 Down from CN¥9.25, the current price target is an average from 4 analysts. New target price is 33% above last closing price of CN¥6.24. Stock is down 33% over the past year. The company is forecast to post earnings per share of CN¥0.25 for next year compared to CN¥0.25 last year. Major Estimate Revision • Sep 05
Consensus revenue estimates fall by 16% The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥2.06b to CN¥1.73b. EPS estimate fell from CN¥0.32 to CN¥0.25 per share. Net income forecast to grow 41% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target down from CN¥9.25 to CN¥8.73. Share price fell 3.7% to CN¥6.23 over the past week. Reported Earnings • Aug 31
Second quarter 2022 earnings: EPS misses analyst expectations Second quarter 2022 results: EPS: CN¥0.05 (down from CN¥0.059 in 2Q 2021). Revenue: CN¥422.2m (up 25% from 2Q 2021). Net income: CN¥50.7m (down 15% from 2Q 2021). Profit margin: 12% (down from 18% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 57%. Over the next year, revenue is forecast to grow 27%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 6% per year. Reported Earnings • May 02
First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind First quarter 2022 results: EPS: CN¥0.082. Revenue: CN¥368.2m (down 19% from 1Q 2021). Net income: CN¥59.3m (down 26% from 1Q 2021). Profit margin: 16% (down from 18% in 1Q 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 27%. Earnings per share (EPS) exceeded analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 43%, compared to a 42% growth forecast for the industry in China. Price Target Changed • Apr 27
Price target decreased to CN¥8.76 Down from CN¥9.58, the current price target is an average from 5 analysts. New target price is 65% above last closing price of CN¥5.31. Stock is down 37% over the past year. The company is forecast to post earnings per share of CN¥0.29 for next year compared to CN¥0.25 last year. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 4 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Major Estimate Revision • Mar 16
Consensus EPS estimates fall by 20% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥2.42b to CN¥2.23b. EPS estimate also fell from CN¥0.56 per share to CN¥0.45 per share. Net income forecast to grow 30% next year vs 47% growth forecast for Chemicals industry in China. Consensus price target down from CN¥15.62 to CN¥13.42. Share price rose 2.7% to CN¥9.17 over the past week. Price Target Changed • Mar 12
Price target decreased to CN¥13.62 Down from CN¥15.62, the current price target is an average from 5 analysts. New target price is 43% above last closing price of CN¥9.55. Stock is down 14% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.35 last year. Reported Earnings • Mar 10
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: CN¥0.35 (down from CN¥0.50 in FY 2020). Revenue: CN¥1.62b (down 14% from FY 2020). Net income: CN¥249.5m (down 31% from FY 2020). Profit margin: 15% (down from 19% in FY 2020). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.1%. Earnings per share (EPS) also missed analyst estimates by 5.8%. Over the next year, revenue is forecast to grow 49%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Price Target Changed • Nov 25
Price target decreased to CN¥15.87 Down from CN¥17.31, the current price target is an average from 4 analysts. New target price is 29% above last closing price of CN¥12.30. Stock is down 12% over the past year. The company is forecast to post earnings per share of CN¥0.37 for next year compared to CN¥0.50 last year. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.065 (vs CN¥0.13 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥367.2m (down 21% from 3Q 2020). Net income: CN¥47.1m (down 51% from 3Q 2020). Profit margin: 13% (down from 21% in 3Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 28% per year. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS CN¥0.083 (vs CN¥0.22 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥336.8m (down 37% from 2Q 2020). Net income: CN¥59.6m (down 62% from 2Q 2020). Profit margin: 18% (down from 29% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 35% per year. Reported Earnings • Apr 20
First quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.091 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥452.2m (up 41% from 1Q 2020). Net income: CN¥80.4m (up 25% from 1Q 2020). Profit margin: 18% (down from 20% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Mar 10
New 90-day low: CN¥11.12 The company is down 29% from its price of CN¥15.60 on 10 December 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Jan 13
New 90-day low: CN¥12.39 The company is down 21% from its price of CN¥15.78 on 15 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.21 per share. Is New 90 Day High Low • Dec 28
New 90-day low: CN¥13.46 The company is down 9.0% from its price of CN¥14.80 on 29 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.94 per share. Reported Earnings • Oct 26
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥354.1m, up 106% from the prior year. Total revenue was CN¥1.71b over the last 12 months, up 54% from the prior year. Reported Earnings • Oct 23
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥354.1m, up 106% from the prior year. Total revenue was CN¥1.71b over the last 12 months, up 54% from the prior year. Announcement • Oct 19
Chongqing Zaisheng Technology Co., Ltd. to Report Q3, 2020 Results on Oct 22, 2020 Chongqing Zaisheng Technology Co., Ltd. announced that they will report Q3, 2020 results on Oct 22, 2020